Book contents
- Seminars in Clinical Psychopharmacology
- College Seminars Series
- Seminars in Clinical Psychopharmacology
- Copyright page
- Contents
- Contributors
- Foreword
- Preface
- Editor’s Note on Nomenclature
- Neuroscience-Based Nomenclature Glossary
- Abbreviations
- Part 1 Basic Science and General Principles
- Part 2 Psychopharmacology of the Main Psychotropic Drug Groups
- Chapter 7 Drugs to Treat Depression
- Chapter 8 Drugs to Treat Anxiety and Insomnia
- Chapter 9 Drugs to Treat Schizophrenia and Psychosis (Dopamine Antagonists and Partial Agonists Other Than Clozapine)
- Chapter 10 Clozapine
- Chapter 11 Lithium
- Chapter 12 Anticonvulsants for Mental Disorders: Valproate, Lamotrigine, Carbamazepine and Oxcarbazepine
- Chapter 13 Drugs to Treat Attention Deficit Hyperactivity Disorder (ADHD)
- Chapter 14 Drugs to Treat Dementia
- Chapter 15 Drugs to Treat Substance Use Disorders
- 15.1 Diagnosis
- 15.2 Nicotine Dependence and Withdrawal
- 15.3 Drugs to Treat Nicotine Dependence
- 15.4 Alcohol Use Disorders
- 15.5 Drugs to Manage Alcohol Withdrawal Syndrome
- 15.6 Drugs for Relapse Prevention in Alcohol Dependence
- 15.7 Opioid Dependence and Withdrawal
- 15.8 Opioid Substitution Therapy
- 15.9 Opioid Detoxification Treatments
- 15.10 Naltrexone for Relapse Prevention in Opioid Dependence
- 15.11 Management of Opioid Overdose and Take-Home Naloxone
- 15.12 Benzodiazepine Dependence and Withdrawal
- 15.13 Pharmacological Management of Benzodiazepine Withdrawal/Dependence
- 15.14 Other Common Drugs of Misuse
- Contents
- Chapter 16 Electroconvulsive Therapy and Neuromodulation Therapies
- Part 3 Specific Therapeutic Areas
- Index
Contents
from Chapter 15 - Drugs to Treat Substance Use Disorders
Published online by Cambridge University Press: 29 May 2020
- Seminars in Clinical Psychopharmacology
- College Seminars Series
- Seminars in Clinical Psychopharmacology
- Copyright page
- Contents
- Contributors
- Foreword
- Preface
- Editor’s Note on Nomenclature
- Neuroscience-Based Nomenclature Glossary
- Abbreviations
- Part 1 Basic Science and General Principles
- Part 2 Psychopharmacology of the Main Psychotropic Drug Groups
- Chapter 7 Drugs to Treat Depression
- Chapter 8 Drugs to Treat Anxiety and Insomnia
- Chapter 9 Drugs to Treat Schizophrenia and Psychosis (Dopamine Antagonists and Partial Agonists Other Than Clozapine)
- Chapter 10 Clozapine
- Chapter 11 Lithium
- Chapter 12 Anticonvulsants for Mental Disorders: Valproate, Lamotrigine, Carbamazepine and Oxcarbazepine
- Chapter 13 Drugs to Treat Attention Deficit Hyperactivity Disorder (ADHD)
- Chapter 14 Drugs to Treat Dementia
- Chapter 15 Drugs to Treat Substance Use Disorders
- 15.1 Diagnosis
- 15.2 Nicotine Dependence and Withdrawal
- 15.3 Drugs to Treat Nicotine Dependence
- 15.4 Alcohol Use Disorders
- 15.5 Drugs to Manage Alcohol Withdrawal Syndrome
- 15.6 Drugs for Relapse Prevention in Alcohol Dependence
- 15.7 Opioid Dependence and Withdrawal
- 15.8 Opioid Substitution Therapy
- 15.9 Opioid Detoxification Treatments
- 15.10 Naltrexone for Relapse Prevention in Opioid Dependence
- 15.11 Management of Opioid Overdose and Take-Home Naloxone
- 15.12 Benzodiazepine Dependence and Withdrawal
- 15.13 Pharmacological Management of Benzodiazepine Withdrawal/Dependence
- 15.14 Other Common Drugs of Misuse
- Contents
- Chapter 16 Electroconvulsive Therapy and Neuromodulation Therapies
- Part 3 Specific Therapeutic Areas
- Index
- Type
- Chapter
- Information
- Seminars in Clinical Psychopharmacology , pp. 454 - 455Publisher: Cambridge University PressPrint publication year: 2020